Skip to main content

Jason A. Keyes

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jason A. Keyes

Earlier roles on record: Board Member at Carisma Therapeutics Inc. until March 7, 2023. Carisma Therapeutics Inc. reported in an 8-K filed March 8, 2023 that Jason A. Keyes resigned as Board, effective March 7, 2023.

“Thomas R. Cannell, Jay S. Duker, M.D., Peter K Honig, M.D., Michael A.S. Jewett, M.D., Jason A. Keyes and Carrie L. Bourdow resigned from the Board and committees of the Board on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company's operations, policies or practices.”
Carisma Therapeutics Inc. Form 8-K, filed March 8, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Carisma Therapeutics Inc.

    Board Member

    Proxy statement

    Start not stated–2023-03-07

Company network

Recorded roles and call appearances connecting this person to public companies.

Carisma Therapeutics Inc.

Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.